mitoxantrone , 1,4-dihydroxy-5,8-bis ( ( ( 2- [ ( 2-hydroxyethyl ) amino ] ethyl ) amino ) ) -9,10-anthracenedione dihydrochloride , a new antitumor agent was evaluated in nine cancer patients as part of a phase i trial .
C0026259
mitoxantrone
C0003174
anthracenedione